Perceptive Advisors’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-200,000
Closed -$125K 124
2019
Q1
$125K Hold
200,000
﹤0.01% 101
2018
Q4
$308K Buy
+200,000
New +$3.97M 0.01% 95

Perceptive Advisors's IMMU Position: Q4 2020 in Review

Perceptive Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 912,140 shares — an estimated $77.6M sold.

Perceptive Advisors first reported a position in IMMU in Q2 2013 and held it in 13 quarters. The position peaked at $77.6M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Perceptive Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Perceptive Advisors sold 912,140 Immunomedics Inc shares in Q4 2020, an estimated $77.6M.
  • Perceptive Advisors first reported a position in Immunomedics Inc in Q2 2013 and held it in 13 quarters.
  • Perceptive Advisors's Immunomedics Inc position peaked at $77.6M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Perceptive Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.